Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Mellitus With Oral Complications”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Large-scale testing (Phase 3)Study completedNCT05803421
What this trial is testing

Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

Who this might be right for
Type 2 DiabetesObesityOverweight or Obesity+3 more
Eli Lilly and Company 2,749
Not applicableStudy completedNCT03644004
What this trial is testing

Oral Glucose Tolerance Test and Post Partum Diagnosis of Diabetes Mellitus, Type 2 (DT2 Post-Partum)

Who this might be right for
Gestational Diabetes
Hospices Civils de Lyon 173
Testing effectiveness (Phase 2)Study completedNCT00375960
What this trial is testing

A Research Study of V3381 for the Treatment of Diabetic Peripheral Neuropathic Pain

Who this might be right for
PainDiabetic Neuropathies
Vernalis (R&D) Ltd 50
Large-scale testing (Phase 3)WithdrawnNCT00228904
What this trial is testing

Effects of Pulsatile Intravenous Insulin Delivery on Diabetic Neuropathy in pATIENTS (Pts) With Type 1 and Type 2 Diabetes

Who this might be right for
Diabetic Neuropathy
Florida Atlantic University
Large-scale testing (Phase 3)WithdrawnNCT07057479
What this trial is testing

Phase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diabetes Patients on Metformin

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Eurofarma Laboratorios S.A.
Large-scale testing (Phase 3)Ended earlyNCT00287651
What this trial is testing

Effects of Pulsatile IV Insulin Delivery on Diabetic Retinopathy in Patients With Types 1 and 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, With Complications
Florida Atlantic University 150
Post-approval studies (Phase 4)UnknownNCT01316068
What this trial is testing

Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients

Who this might be right for
Diabetic NephropathyAlbuminuria
Sun Yat-sen University 80
Testing effectiveness (Phase 2)Study completedNCT01756703
What this trial is testing

Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria

Who this might be right for
Diabetic Nephropathy
Tanabe Pharma Corporation 67
Early research (Phase 1)UnknownNCT01319734
What this trial is testing

Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Al-Neelain University 50
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Testing effectiveness (Phase 2)Study completedNCT03412006
What this trial is testing

Study to Investigate Efficacy, Safety and Tolerability of BAY1142524 in Patients With Type II Diabetes and a Clinical Diagnosis of Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Bayer 152
Early research (Phase 1)Study completedNCT00501462
What this trial is testing

A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

Who this might be right for
Type 2 Diabetes MellitusDiabetes Mellitus, Type 2Renal Insufficiency
GlaxoSmithKline 29
Not applicableUnknownNCT05809817
What this trial is testing

Oral Health Policy for Patients With Type 2 Diabetes Mellitus in Chile: A Microsimulation Model Based on Real-world Data

Who this might be right for
Type 2 Diabetes MellitusPeriodontitisDiabetic Complication+1 more
University of Chile 135
Testing effectiveness (Phase 2)Study completedNCT02010242
What this trial is testing

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

Who this might be right for
Type 2 Diabetes Mellitus With Diabetic Nephropathy
Calliditas Therapeutics AB 136
Early research (Phase 1)Looking for participantsNCT07619157
What this trial is testing

ONO-3310 in Healthy Adult Male Subjects and Chronic Kidney Disease Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type2 Diabetes MellitusChronic Kidney Disease
Ono Pharmaceutical Co., Ltd. 120
Not applicableStudy completedNCT07498894
What this trial is testing

Salivary and Serum Inflammatory Biomarkers in Diabetic Nephropathy by Periodontal Status

Who this might be right for
Diabetic Nephropathy Type 2Type 2 DiabetesPeriodontitis+2 more
Pamukkale University 126
Large-scale testing (Phase 3)Ended earlyNCT00228891
What this trial is testing

Effects of Pulsatile Insulin Delivery on Diabetic Neuropathy in Patients With Types 1 and 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, With Complications
Florida Atlantic University 152
Testing effectiveness (Phase 2)Study completedNCT00287183
What this trial is testing

6-Month Safety And Efficacy Study Of TTP488 In Patients With Type 2 Diabetes And Persistent Albuminuria

Who this might be right for
Diabetic Nephropathy
Pfizer 110
Testing effectiveness (Phase 2)Study completedNCT01874431
What this trial is testing

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathies
Bayer 823
Testing effectiveness (Phase 2)Study completedNCT01968668
What this trial is testing

Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)

Who this might be right for
Diabetic Nephropathies
Bayer 96
Next Page